Structurally, the cochlea is a three-dimensional device which mechanically separates out frequency components from a complex sound stimulus. Not only does sound have to be delivered correctly to the cochlea via the middle ear, but it also has to produce the correct vibration pattern in the basilar and tectorial membranes of the cochlear partition. We also now know that the mammalian cochlea employs amplification processes to boost the incoming sound [2] , and that the gain has to be set critically. Hence, small alterations in the structure or function of a component could lead to 40 decibel (equivalent to 100-fold) changes in hearing thresholds or more -a substantial hearing loss. Consequently, defects could arise through changes to the cochlea during development, through altered function of the epithelia and mature structures of the cochlea, or through specific lesions to the hair cells (Fig. 1) .
The sequence of steps in cochlear development is not known with any certainty, and the genetics and molecular biology of the auditory system, unlike that of the visual system where the genetic determinants of colour vision have been traced to molecular scales, are still relatively immature. In part this is because the amounts of material available for study are small, but it also arises because of the relatively greater difficulty of detecting hearing losses and of being able to identify the precise target of the mutation.
There are well over twenty known distinct hereditary deafnesses in humans [1] . Some of the hearing losses present variably in association with a larger set of disorders, and are described as syndromic. One of these, Waardenburg's syndrome, has been the object of considerable attention. Subjects presenting this form of deafness show variable degrees of hearing losses, pigmentary disturbances and a recognizable flattening of the facial features (dystopia canthorum). Waardenburg syndrome type 1 has recently been associated with a mutation of the Fig. 1 . Cross section of the mammalian cochlear duct (the organ of Corti is enlarged) showing possible targets of genetic mutations leading to hearing losses: hair cells (pink); tectorial membrane (light blue), which contains collagens and tectorins [5] ; non-sensory cells of the organ of Corti (yellow); basilar membrane (lilac), which establishes cochlear mechanics; stria vascularis (orange), which maintains endocochlear potential; cochlear morphogenesis -for example, development of the embedding bone (light grey).
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to close correctly. This may prevent the formation of the correct ionic environment for the sensory cells within the mature cochlea.
Non-syndromic hearing losses, not necessarily associated with other readily identifiable features, stand a better chance of pointing to a cochlea-specific gene defect. They are harder to identify because the locus may be masked by variability, but some types of deafness have been identified in human populations because the families are sufficiently extended and good records exist. Recent progress has been made in mapping a progressive hearing loss to chromosome 5q in one family and a recessive deafness to chromosome 13q in another, although the candidate genes have yet to be identified.
Easier to explore are hearing losses that are X-linked. Of these, Alport's syndrome, which is a hereditary deafness associated with kidney pathology, has received much attention because there is a candidate gene. The gene is linked to a site on chromosome Xq22 where nearby deletions cause defects in type IV collagen, a collagen that is found in kidney basement membranes. In addition to Alport's syndrome, there is evidence that some forms of sensori-neural hearing loss may be associated with collagen deficits -particularly of types I, II, IV and XI. These 'structural' deficits also seem attractive because some of the key structures within the mammalian cochlea, in particular the tectorial membrane and the basilar membrane [5] , involve collagen filaments.
USH1B mapping to chromosome llq. Weil et al. [7] have now provided evidence that this gene encodes a previously characterized sequence of 31 residues that was classified as myosin VIIA.
Mice that are homozygous for mutations of the gene sh 1 are characterized by disorders in functional hearing and balance, although there is no significant degeneration of cochlear structure. The shl gene maps to mouse chromosome 7 and appears to be homologous either to USHB1 or to DFNB2, a human neurosensory deafness gene, which is not associated with retinal degeneration. Gibson et al. [8] have now shown that the mouse gene sh also encodes the head domain of a type VII myosin. In the three mutant forms of shl studied to date, all had mutations that might be expected to lead to defects in the myosin head group.
A more direct approach to identifying inner-ear-specific proteins surprisingly yielded a collagen as the gene product [6] . Differential screening of a cDNA library prepared from sunfish sacculus produced a cDNA encoding a collagen with extensive homology to collagen types VIII and X, both members of short-chain collagen families. In situ hybridization studies suggest that the collagens are being produced by the supporting cells and that the final target is the overlying otolithic membrane, the equivalent of the tectorial membrane in the cochlea, which couples the displacement stimulus to the stereocilia.
Despite being able to offer more tissue, the teleost sacculus differs significantly from the mammalian cochlea, and the pursuit of a gene product more closely related to hair-cell function seems desirable. Two recent reports [7, 8] identify such a gene in human populations with Usher syndrome type 1B, and in a mouse homologue, shaker-1 (sh 1), which encodes a myosin.
Usher's syndrome patients exhibit hearing loss, disturbance of vestibular function and retinitis pigmentosa. In type I syndrome, the retinitis pigmentosa has early onset and the pathology is often associated with microtubular disorganization and with degeneration of the cochlea. It is known that a single gene is not responsible for the full expression of the syndrome (at least seven genes are implicated in the human populations), but 75 % of the patients exhibiting the syndrome possess a defective gene Fig. 2 . Hair cell structure. Actin-filled stereocilia project from the apical end and are displaced by the stimulus. Myosin immunoreactivity is reported in hair cells on and below the stereocilia and below the nucleus. Inset shows tip-links between stereocilia. The tip-links, it is proposed [10] , gate the mechanoelectrical transducer channels in the membrane and are retensioned by a cluster of myosin molecules which continuously slide up along the actin core of the stereocilia.
Although myosins first appeared as the motor molecules in muscle, the family is extensive [9] . It contains classes which depend for their classification not only on the tail, but also on sequence differences in the head group. The myosin class VII is one of the so-called 'unconventional' myosins; myosins of class VII have been found in a pig kidney cell line and in Drosophila, but as yet no representative of this class has been functionally characterized. Myosins made their appearance in the hair-cell literature over a decade ago, and were initially implicated in the process of sound amplification in the cochlea. This idea is currently not in vogue, and other mechanisms of amplification are thought to be employed [2] .
There is, however, evidence that a short-tail myosin, myosin 1, may be involved in the first steps of mechano-transduction in hair cells, at least in the hair cells found in the frog sacculus. Mechano-electrical transduction in all hair cells involves deflection of the stereocilia (Fig. 2) . When the stereocilia are deflected, it is believed that transducer channels near the stereocilial tips are gated open. The molecular identity of the coupling between stereocilial deflection and transducer channel is not known [10] , but the favoured mechanism employs a connection between the stereocilia, a 'tip link', which transfers energy to the ion channel for gating. The efficiency of this mechanism depends on tension being maintained in the link. The tensioning mechanism, it is proposed, uses myosin motors which pull the link tight. There is evidence that this tensioning process, or adaptation motor, depends on myosin 1 [11, 12] . The conclusion depends on the identification of 13 different myosins, the products of 10 different genes, expressed in hair cells and supporting cells of the bullfrog saccular macula [11] . Antibodies raised against myosin 1 label the tips of the hair-cell stereocilia, and the identified myosin contains ATP-and calmodulin-binding sites, for both of which there is physiological support.
Myosin VII and myosin 13 are not, however, the same. The appearance of myosins associated with auditory transduction in two different contexts may be fortuitous, and it has yet to be shown that the product of the sh 1 gene is associated with the hair cells (although a rat outer-hair-cell cDNA library is reported to include an appropriately sized product [8] ). It might be the case that different myosins are employed for the adaptation motor in mammals, distinct from those of frog inner-ear systems. Alternatively, it could be that shl and the USHIB gene on chromosome 11 encode a myosin involved in 'housekeeping' operations in cells of the cochlea, such as vesicle transport or microvillous organization, as suggested by the extensive microtubular structures near the apical membrane of hair cells. Clearly, there are further localization and gene-knockout experiments to be performed, and such experiments are possible now that the mouse models have been established. Nevertheless, the identification of a motor protein as the gene product of shl/USHIB takes us one step forward to understanding and, perhaps, preventing hearing losses.
